<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="929">
  <stage>Registered</stage>
  <submitdate>6/12/2005</submitdate>
  <approvaldate>10/01/2006</approvaldate>
  <actrnumber>ACTRN12606000016538</actrnumber>
  <trial_identification>
    <studytitle>COAST study</studytitle>
    <scientifictitle>Chronic Obstructive Pulmonary Disease (COPD) Observational and Surveillance Trial</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Chronic Obstructive Pulmonary Disease (COPD)</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Chronic obstructive pulmonary disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>NIL</interventions>
    <comparator />
    <control />
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Assemble a prospective cohort of patients with COPD in Victoria</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Provide information on the prevalence of virus infections in health and during exacerbations.
Will yield new knowledge about mechanisms implicated in the progressive loss of lung function in COPD</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>COPD diagnosisFEV1 &lt; 70% predictedReversibility following SABA on predicted FEV1of &lt;10% and/or 200mls.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to tolerate any study procedures.Inability to attend clinic and fill out daily diary.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>6/01/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>A/Professor Peter Holmes</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>A/Prof Philip Bardin</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study over a 2 year period will aim to identify viruses during COPD attacks and try to understand whether they also damage the airway in the process. This is done by assessing lung function, nasal and sputum samples both when well and during an exacerbation.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash Medical Centre Department of Respiratory and Sleep Medicine</ethicname>
      <ethicaddress>Level 2, 246 Clayton Rd, Clayton, VIC, 3168</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor Peter Holmes</name>
      <address>Department of Respiratory and Sleep Medicine
Monash Medical Centre
Level 2
246 Clayton Rd
Clayton VIC 3168</address>
      <phone>+61 3 95942907</phone>
      <fax>+61 3 95947877</fax>
      <email>peter.holmes@southernhealth.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Joanne McKenzie</name>
      <address>Department of Respiratory and Sleep Medicine
Monash Medical Centre
Level 2
246 Clayton Rd
Clayton VIC 3168</address>
      <phone>+61 3 95942279</phone>
      <fax>+61 3 95947877</fax>
      <email>respiratorymedicine.trials@southernhealth.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>